Therapeutics 2000, Inc. has a pipeline of products that take advantage of this system to grow quickly into a major company. The patent that covers aerosol liposome preparations that produce droplets between 1 and 3 microns in diameter. This size range is critical to bypass the filtration system of the bronchial tree and deliver drugs to the deep lung . This invention can be applied to many different drugs, and the Company plans to take full advantage of the opportunity. Improving Existing Drugs There are a number of drugs already on the market that would be more effective if delivered directly to the lungs using our technology.
Pills are needlessly slow to act .
Inc. has in development will not be available to the public for several years. This is because we need to prove in human tests that the concepts we describe are true to the satisfaction of government regulatory authorities before these products can be marketed. Often products turn out to work differently that expected when tested in large numbers of people. The technology behind these products is very broad, and can be used to deliver drugs into the bloodstream through the highly absorbent membranes in the alveoli. Ultimately, we will provide home use products that will enable people to take a broad range of medications by inhaling them, instead of using injections or slow-absorbing pills.